Cynthia Cassandro

Cynthia Cassandro is an accomplished healthcare professional with extensive experience in patient advocacy and access across various leading pharmaceutical companies. Currently serving as Vice President of Patient Advocacy at Vigil Neuroscience since October 2022, Cynthia previously held significant roles, including Head of Global Patient Advocacy at Alexion Pharmaceuticals and Head of Patient Advocacy & Engagement at Voyager Therapeutics. At Biogen, Cynthia built and led sales and patient access organizations for the company's first Rare Disease division, demonstrating strong leadership and strategic execution. Cynthia's career includes vital positions focused on patient services and account management at Shire, Biogen Idec, ELAN Pharmaceuticals, and Janssen Pharmaceutica. Educational qualifications include a Bachelor of Science in Finance and Insurance from Northeastern University and a Registered Nursing degree from St. Vincent's Hospital School of Nursing.